Gallium-68 FAPI-46 PET/CT for inflammation and fibrosis
Part of Immune system & allergy clinical trials.
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a chronic inflammatory or fibrotic disease (like systemic sclerosis, idiopathic pulmonary fibrosis, rheumatoid arthritis, etc.) listed in the study.
- You must meet the official diagnostic criteria for your condition.
- You must have a specific clinical situation the study is looking at (for example, active disease or a certain stage).
- If you are a woman of childbearing age, you need a negative pregnancy test and must use birth control during the study.
- You must have health insurance (social security) and be able to provide signed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging scan (SPECT) that uses a special tracer (99mTc-TCR-FAPI) to see inflammation in the joints of people with rheumatoid arthritis. It aims to help doctors better understand and track disease activity.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
This study tests a new PET scan with a tracer called 68Ga-FAPI-46 to see how well it can find and measure scarring (fibrosis) in the small bowel caused by Crohn's disease. It may help doctors better understand and manage bowel damage.
This study tests whether a new PET/CT scan using a radioactive tracer called FAPI-46 can better see lung changes in people with interstitial lung disease. It might help doctors understand the disease activity better.
This study uses a special PET scan (FAPI PET) to look at inflammation in people with Sjögren's syndrome. It helps doctors understand how active the disease is. You may join if you have Sjögren's syndrome or a solid tumor that needs this scan, and you are not on certain medications.
This study tests whether a new type of PET/CT scan can measure liver scarring (fibrosis) in people with fatty liver disease. It might help doctors check liver damage without needing repeated biopsies.
Hear when a new Inflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.